Literature DB >> 4035635

Streptococcus milleri as a cause of pleural empyema.

D B Hocken, J E Dussek.   

Abstract

Review of an annual series of cases of empyema seen at a regional cardiothoracic unit showed that six out of 25 were due to Streptococcus milleri. The details of the cases are summarised. This organism is now an important cause of empyema, occurring much more commonly in men than in women; but since it is highly sensitive to penicillins permanent resolution can be achieved with antibiotic treatment combined with open or closed drainage.

Entities:  

Mesh:

Year:  1985        PMID: 4035635      PMCID: PMC1020604          DOI: 10.1136/thx.40.8.626

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  10 in total

1.  Staphylococcic empyema.

Authors:  G J MAGOVERN; B BLADES
Journal:  J Am Med Assoc       Date:  1958-09-27

2.  Streptococcus milleri (Guthof); an indigenous organism of the human oral cavity.

Authors:  B Mejàre; S Edwardsson
Journal:  Arch Oral Biol       Date:  1975-11       Impact factor: 2.633

3.  Anaerobic infections of the lung and pleural space.

Authors:  J G Bartlett; S M Finegold
Journal:  Am Rev Respir Dis       Date:  1974-07

4.  Pleural empyema. Changing etiologic, bacteriologic, and therapeutic aspects.

Authors:  A S Geha
Journal:  J Thorac Cardiovasc Surg       Date:  1971-04       Impact factor: 5.209

5.  Serious infections caused by Streptococcus milleri.

Authors:  H W Murray; K C Gross; H Masur; R B Roberts
Journal:  Am J Med       Date:  1978-05       Impact factor: 4.965

6.  Antimicrobial susceptibilities of species of viridans streptococci.

Authors:  A M Bourgault; W R Wilson; J A Washington
Journal:  J Infect Dis       Date:  1979-09       Impact factor: 5.226

7.  Streptococci and aerococci associated with systemic infection in man.

Authors:  M T Parker; L C Ball
Journal:  J Med Microbiol       Date:  1976-08       Impact factor: 2.472

8.  The cultural and biochemical characters of Streptococcus milleri strains isolated from human sources.

Authors:  L C Ball; M T Parker
Journal:  J Hyg (Lond)       Date:  1979-02

9.  Anaerobic pleuro-pulmonary infections.

Authors:  S L Green
Journal:  Postgrad Med       Date:  1979-01       Impact factor: 3.840

10.  Microbiology of pyogenic liver abscess.

Authors:  J C Moore-Gillon; S J Eykyn; I Phillips
Journal:  Br Med J (Clin Res Ed)       Date:  1981-09-26
  10 in total
  7 in total

1.  Rapid developing empyema by group F beta Streptococcus anginosus group.

Authors:  Muhammad Azharuddin; Dy Prudence; Prem Shanker Shukla; Ajay Mathur
Journal:  BMJ Case Rep       Date:  2017-07-13

2.  Empyema thoracis: a problem with late referral?

Authors:  C W Cham; S M Haq; J Rahamim
Journal:  Thorax       Date:  1993-09       Impact factor: 9.139

3.  Seven-year review of bacteremia caused by Streptococcus milleri and other viridans streptococci.

Authors:  M Salavert; L Gómez; M Rodriguez-Carballeira; M Xercavins; N Freixas; J Garau
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-05       Impact factor: 3.267

4.  Streptococcus milleri pulmonary disease: a review and clinical description of 25 patients.

Authors:  C A Wong; F Donald; J T Macfarlane
Journal:  Thorax       Date:  1995-10       Impact factor: 9.139

5.  Clinical Characteristics of Community-Acquired Viridans Streptococcal Pneumonia.

Authors:  Sun Ha Choi; Seung-Ick Cha; Keum-Ju Choi; Jae-Kwang Lim; Hyewon Seo; Seung-Soo Yoo; Jaehee Lee; Shin-Yup Lee; Chang-Ho Kim; Jae-Yong Park
Journal:  Tuberc Respir Dis (Seoul)       Date:  2015-06-30

6.  A successfully treated case of primary purulent pericarditis complicated by cardiac tamponade and pneumopericardium.

Authors:  Jong Wook Beom; Yeekyoung Ko; Ki Yung Boo; Jae-Geun Lee; Joon Hyouk Choi; Seung-Jae Joo; Ji Hwan Moon; Su Wan Kim; Song-Yi Kim
Journal:  Acute Crit Care       Date:  2020-10-12

7.  COMPLICATED PNEUMONIA WITH EMPYEMA CAUSED BY STREPTOCOCCUS ANGINOSUS IN A CHILD.

Authors:  Ana Reis-Melo; Diana Soares; Manuel Ferreira Magalhães; Catarina Ferraz; Luísa Vaz
Journal:  Rev Paul Pediatr       Date:  2020-03-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.